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Abstract 
Background: Patient mortality is significantly reduced by rapid identification of bacteria from sterile sites. MALDI-TOF 
can identify bacteria directly from positive blood cultures and multiple sample preparation methods are available. We 
evaluated three sample preparation methods and two MALDI-TOF score cut-off values. Positive blood culture bottles 
with organisms present in Gram stains were prospectively analysed by MALDI-TOF. Three lysis reagents (Saponin, SDS, 
and SepsiTyper lysis bufer) were applied to each positive culture followed by centrifugation, washing and protein 
extraction steps. Methods were compared using the McNemar test and 16S rDNA sequencing was used to assess 
discordant results.
Results: In 144 monomicrobial cultures, using ≥2.000 as the cut-off value, species level identifications were obtained 
from 69/144 (48%) samples using Saponin, 86/144 (60%) using SDS, and 91/144 (63%) using SepsiTyper. The differ-
ence between SDS and SepsiTyper was not statistically significant (P = 0.228). Differences between Saponin and 
the other two reagents were significant (P < 0.01). Using ≥1.700 plus top three results matching as the cut-off value, 
species level identifications were obtained from 100/144 (69%) samples using Saponin, 103/144 (72%) using SDS, and 
106/144 (74%) using SepsiTyper and there was no statistical difference between the methods. No true discordances 
between culture and direct MALDI-TOF identification were observed in monomicrobial cultures. In 32 polymicrobial 
cultures, MALDI-TOF identified one organism in 34–75% of samples depending on the method.
Conclusions: This study demonstrates two inexpensive in-house detergent lysis methods are non-inferior to a com-
mercial kit for analysis of positive blood cultures by direct MALDI-TOF in a clinical diagnostic microbiology laboratory.
Keywords: MALDI-TOF, Blood culture, Bacteraemia, Sepsis, Identification, Microbiology, Clinical
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Bacteraemia and sepsis have a high mortality rate and it 
is crucial to start appropriate antimicrobial treatment as 
promptly as possible [1, 2]. Conventional identification 
of organisms causing bacteraemia relies on Gram stain-
ing of a positive blood culture followed by solid media 
subculture for 18–24  h and then confirmatory tests to 
identify the causative organism. Whilst empirical antimi-
crobial treatment will have been started at the point of 
blood culture collection, earlier identification of bacteria 
in blood culture would enable the medical microbiolo-
gist to: more specifically target antimicrobial treatment 
(based on intrinsic and local patterns of antimicrobial 
susceptibilities of certain genera or species); instigate fur-
ther relevant investigations; and inform infection preven-
tion and control measures at an earlier stage which could 
potentially reduce mortality rates.
Matrix-Assisted Laser Desorption/Ionization Time-
of-Flight (MALDI-TOF) is an inexpensive method that 
can identify a broad range of bacterial species directly 
from positive blood cultures [3]. Numerous methodolo-
gies for preparation of positive blood culture samples for 
MALDI-TOF have been described with a central aim 
of producing a bacterial pellet that is free from human 
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blood cells, proteins, and culture medium. This can be 
achieved by detergent lysis of the human cells followed 
by centrifugation and washing steps of the bacterial pel-
let using a commercial kit or various other reagents (e.g. 
saponin and sodium dodecyl sulphate (SDS) solution) [3–
7]. Other methods have utilised serum separator tubes 
[8–10], differential centrifugation or sedimentation [5, 
11–14] and ammonium chloride lysis [15]. A subsequent 
protein extraction step on the pellet is usually required to 
obtain high yields and high quality results.
In this study we assessed the performance of a com-
mercial kit (Bruker SepsiTyper), two different detergent 
lysis reagents (5% saponin solution, 10% SDS solution) 
and two different MALDI-TOF score cut-off values for 
the identification of bacteria in positive blood culture 
bottles.
Methods
Study setting
The Public Health Laboratory, Birmingham, UK provides 
a diagnostic microbiology service to the Heart of England 
NHS Foundation Trust in Birmingham from whom it 
receives about 27,000 blood culture samples per year. All 
blood culture bottles are incubated and microbial growth 
is detected using the BacT/ALERT® system (bioMé-
rieux). Blood culture media used are BacT/ALERT® SA 
Standard Aerobic, BacT/ALERT® SN Standard Anaero-
bic and BacT/ALERT® FA Plus (antimicrobial neutraliza-
tion) media (bioMérieux). No charcoal containing bottles 
are used. When blood culture bottles flag positive on 
the system (indicating microbial growth), aliquots of the 
blood culture medium are used to prepare Gram stains 
and agar plate subcultures for identification of cultured 
organisms. The laboratory routinely uses MALDI-TOF 
(Bruker MALDI Biotyper system) for identification of 
bacterial isolates from agar plates. Some bacterial spe-
cies are confirmed with biochemical tests in addition to 
MALDI-TOF according to ISO 15189:2012 United King-
dom Accreditation Service accredited methods used for 
routine clinical diagnostics. Routine clinical diagnostic 
results reported by the laboratory were considered the 
definitive result with which direct MALDI-TOF results 
(see below) were compared.
Study sample collection
On weekdays, over a four week period in December 2013, 
all blood cultures from patients ≥18  years old which 
flagged positive on the BacT/ALERT® (bioMérieux) sys-
tem and had micro-organisms seen in the Gram stain 
were selected. All selected blood cultures were prepared 
for direct MALDI-TOF using three different lysis rea-
gents in parallel (as described below) in addition to rou-
tine Gram stain and sub-culture methods.
Direct identification of micro‑organisms in positive blood 
cultures by MALDI‑TOF
Two hundred microliters of each of the three lysis rea-
gents (5% Saponin solution, 10% SDS solution, Bruker 
SepsiTyper Lysis Buffer) were aliquoted into a new 
screw-capped microcentrifuge tubes and 1  ml of each 
positive blood culture was added to each tube. All 
tubes were vortex mixed for 10 s and then incubated at 
room temperature for 5 min and centrifuged for 1 min 
at 13,000g. Supernatant was removed and each pellet 
was re-suspended in either 1  ml MALDI grade water 
for Saponin or SDS or 1 ml SepsiTyper Washing Buffer 
and centrifuged for 1  min at 13,000g. Supernatant was 
again removed and each pellet re-suspended in 300  μl 
MALDI grade water and 900  μl 100% Ethanol followed 
by centrifugation for 2 min at 13,000g. The supernatant 
was then removed and each sample centrifuged again 
for 2 min at 13,000g. Residual ethanol was then removed 
and the pellets dried for 10  min at room temperature. 
Pellet size was then estimated. For small or non-visible 
pellets, 5 µl of 70% formic acid and 5 µl of 100% Acetoni-
trile was added. For medium-sized pellets, 20 µl of 70% 
formic acid and 20  µl of 100% Acetonitrile was added. 
For large pellets, 50  µl of 70% formic acid and 50  µl of 
100% Acetonitrile was added. Pellets were re-suspended 
thoroughly then each sample was centrifuged for 2 min 
at 13,000g. One microliter of each supernatant was then 
spotted onto a sample spot of a MALDI target plate and 
allowed to dry. Two spots were prepared for each sam-
ple. One microliter of α-Cyano-4-hydroxycinnamic acid 
(HCCA) matrix solution (Bruker) was then added to 
each spotted sample and allowed to dry. Genus and spe-
cies identification was then obtained using the Bruker 
MALDI Biotyper system.
MALDI‑TOF data analysis
Spectra were automatically captured and analysed by the 
Bruker MALDI Biotyper system and database (version 
2.0, IVD MALDI Biotyper database 4613). No manual 
acquisition was carried out. Two MALDI spots were 
analysed for each positive bottle and the highest scoring 
spot was selected for data analysis. Two different MALDI 
scoring methods were used: acceptable genus and species 
identification if a score ≥2.000 was obtained or accepta-
ble genus and species identification if a score ≥1.700 and 
the top three matches were concordant. Samples giving 
scores below the cut off values evaluated were recorded 
as having no identification by direct MALDI-TOF.
16S rDNA PCR and capillary electrophoresis
Samples with discordant results between direct MALDI-
TOF and the diagnostic laboratory’s reported identifica-
tion from agar plates were analysed by 16S rDNA PCR 
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and DNA sequence analysis. DNA sequences were que-
ried against NCBI BLAST [16].
Data analysis
Within the study period, the first positive aerobic and 
anaerobic blood culture bottle from each patient was 
selected for data analysis. The McNemar test was used 
to evaluate if the differences observed between the three 
different lysis methods were statistically significant.
All MALDI-TOF testing was carried out without inves-
tigators seeing the Gram stain or conventional culture 
and identification results. At the conclusion of the study 
period, reported results of culture and identification by 
the clinical diagnostic laboratory for all positive blood 
cultures were downloaded from the laboratory informa-
tion system for comparison with the direct MALDI-TOF 
results obtained.
Results
During the four week study period, a total of 199 blood 
culture bottles from 122 patients flagged positive and 
organisms were seen on the Gram stain. Of the 199 
bottles, 10 were antimicrobial neutralization, 99 were 
standard aerobic and 90 were standard anaerobic media. 
Species identified from the individual bottles by direct 
MALDI-TOF are shown in Table  1. The first positive 
aerobic and/or anaerobic bottle(s) from each patient 
was included for further study giving 181 blood cultures 
(including 63 sets of two bottles) from 122 patients.
Of the 181 positive cultures, five failed to grow on 
sub-culture. Of the 15 direct MALDI-TOF results from 
these bottles, 14 gave no identification. In one bottle, 
Corynebacterium mucifaciens was identified with a score 
of 1.729 using SDS. Gram positive bacilli had been seen 
in the Gram stain.
Thirty-two of the 181 positive blood cultures showed 
polymicrobial growth (≥2 different species) on subcul-
ture. Two or more organisms were seen on the Gram 
stain in only 3/32 (9%) bottles with at least one organ-
ism seen in all 32 bottles. In 12/32 (38%) samples both 
organisms grown would have had the same morphology 
on Gram stain. Where direct MALDI-TOF identifica-
tions were obtained for polymicrobial culture bottles, 
MALDI-TOF only ever identified one organism from 
a bottle. Using Saponin, MALDI-TOF identified a sin-
gle organism in 11/32 (34%) polymicrobial bottles using 
≥2.000 and 20/32 (63%) bottles using ≥1.700 and the 
top three matches were concordant as a cut-off score 
respectively. Using SDS, a single organism was identi-
fied in 21/32 (66%) or 24/32 (75%) bottles respectively. 
Using SepsiTyper, a single organism was identified in 
22/32 (69%) or 24/32 (75%) bottles respectively. Where 
obtained, the direct MALDI-TOF identifications were 
always concordant with the single organisms identified in 
the Gram stain and at least one of the organisms seen in 
Gram stains with two organisms seen.
One hundred and forty-four positive blood cultures 
from 100 patients had one organism identified from 
conventional subculture (monomicrobial). These were 
selected for further detailed analysis to identify the yield 
of identifications with direct MALDI-TOF and the con-
cordance of these direct identifications with conventional 
identifications from sub-cultured organisms. Direct 
MALDI-TOF identifications using both cut off strategies 
for monomicrobial bottles were compared with organism 
identifications from subcultures. Each direct MALDI-
TOF result was thus determined to be concordant with 
subculture, discordant with subculture or “No ID” where 
no reliable identification using the cut off was obtained. 
These results, broken down by bacterial groups and cut 
off score are shown in Table 2.
In the 144 monomicrobial cultures, using ≥2.000 as the 
cut-off value, the lowest yield of identification to species 
level was obtained with Saponin and the highest yield was 
obtained using SepsiTyper (Table  2). No discordances 
between the organisms identified by direct MALDI-TOF 
and the corresponding report from routine diagnostic 
culture were observed using ≥2.000 as the cut-off value.
The proportion of samples with identification to species 
level was increased by amending the MALDI-TOF cut-
off value to ≥1.700 and top three results matching. How-
ever, two discordances from two samples were observed 
(Table  2). These discordances were further investigated; 
in the first sample Corynebacterium tuberculostearicum 
was identified by MALDI-TOF using the SepsiTyper 
method only (also confirmed using PCR and sequencing 
of the 16S gene from the blood culture) but the culture 
results had been reported as “Propionibacterium sp.”. Fur-
ther examination of laboratory notes indicated that the 
identification of a Propionibacterium sp. was made on 
colony and Gram morphology only indicating that the 
reported culture result may have been imprecise and that 
there was no true discordance. In the second discrepant 
sample the three MALDI-TOF preparation methods and 
16S PCR with sequencing all consistently detected Staph-
ylococcus epidermidis in the aerobic bottle and Actinomy-
ces oris in the anaerobic bottle but the culture results had 
been reported as “S. epidermidis”. Further examination of 
laboratory notes indicated that a faint growth of another 
organism had been noted on anaerobic plates but identi-
fication was not pursued as the isolate was not thought to 
be clinically significant, again indicating that the reported 
culture result was incomplete and that there was no true 
discordance.
The difference in yield of culture concordant identifica-
tions by direct MALDI-TOF using both cut-off strategies 
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Table 1 Direct MALDI-TOF results from 199 blood culture bottles by lysis method and cut off value used
Cut off value ≥1.700 = ≥1.700 and top three results matching
Species identified Number of identifications of each species made by direct MALDI‑TOF from a single blood culture 
bottle using:
Cut off value ≥ 1.700 Cut off value ≥ 2.000
Saponin SDS Sepsi‑Typer Saponin SDS Sepsi‑Typer
Gram positives
 Actinomyces oris 1 1 1 0 0 0
 Clostridium innocuum 1 0 0 0 0 0
 Corynebacterium amycolatum 1 1 1 0 1 0
 Corynebacterium mucifaciens 0 1 0 0 0 0
 Corynebacterium tuberculostearicum 0 0 1 0 0 0
 Enterobacter cloacae 3 3 3 2 3 3
 Enterococcus faecalis 4 4 4 0 2 3
 Enterococcus faecium 2 7 7 1 7 7
 Granulicatella adiacens 0 1 1 0 1 1
 Kocuria rhizophila 0 1 1 0 0 0
 Micrococcus luteus 2 3 3 1 2 2
 Propionibacterium acnes 0 2 3 0 1 2
 Staphylococcus aureus 18 17 17 12 16 17
 Staphylococcus capitis 13 11 13 8 7 6
 Staphylococcus cohnii 0 1 1 0 1 1
 Staphylococcus epidermidis 23 19 17 11 8 7
 Staphylococcus haemolyticus 2 2 2 0 1 2
 Staphylococcus hominis 11 10 11 8 10 10
 Streptococcus agalactiae 1 1 1 0 1 1
 Streptococcus anginosus 1 0 0 0 0 0
 Streptococcus constellatus 1 1 2 0 0 0
 Streptococcus dysgalactiae 0 1 1 0 0 0
 Streptococcus intermedius 0 1 1 0 0 0
 Streptococcus lutetiensis 0 1 1 0 0 0
 Streptococcus mutans 0 2 1 0 1 1
 Streptococcus parasanguinis 0 1 1 0 0 1
 Streptococcus pneumoniae 0 1 1 0 1 1
 Streptococcus pyogenes 0 3 3 0 2 3
 Streptococcus sanguinis 1 4 4 0 2 3
Gram negatives
 Bacteroides fragilis 2 0 0 2 0 0
 Escherichia coli 32 35 36 28 34 36
 Klebsiella oxytoca 3 3 3 3 3 3
 Klebsiella pneumoniae 5 5 5 4 5 5
 Moraxella catarrhalis 1 1 1 0 1 1
 Morganella morganii 2 2 2 2 2 2
 Proteus mirabilis 4 4 4 3 3 4
 Pseudomonas aeruginosa 3 2 3 3 2 2
 Serratia marcescens 3 2 3 1 2 3
 Serratia ureilytica 0 1 0 0 1 0
No identification 59 44 40 110 79 72
Total 199 199 199 199 199 199
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was evaluated with the McNemar test using a signifi-
cance level of P  <  0.05. None of the differences in yield 
between methods using ≥1.700 and top three results 
matching were statistically significantly different in this 
evaluation (Saponin vs. SDS P  =  0.8445; Saponin vs. 
SepsiTyper P = 0.4414; SDS vs. SepsiTyper P = 0.5465). 
Using the ≥2.000 scoring system, the difference in yield 
between SDS and SepsiTyper was not statistically sig-
nificant (P =  0.2278). Differences between Saponin ver-
sus SDS or Saponin versus SepsiTyper were significant 
(P = 0.0125 and P = 0.0015 respectively).
Discussion
This study is the first to perform a three way comparison 
of the SepsiTyper kit with two detergent lysis methods 
for preparing positive blood cultures for direct MALDI-
TOF analysis prospectively in a clinical setting.
Using a cut off score of ≥2.000 (i.e. the manufacturer’s 
recommended cut off value for identification of organ-
isms from culture plates) there was no statistical differ-
ence found between the rates of obtaining sub-culture 
concordant species level identifications using 10% SDS 
or SepsiTyper to prepare monomicrobial positive blood 
cultures for direct MALDI-TOF. Rates of identification 
were 60% and 63% respectively. The use of 5% Saponin 
with a cut off score of ≥2.000 was found to give signifi-
cantly fewer reliable species level MALDI-TOF identifi-
cations from direct blood cultures that either of the other 
methodologies.
Using a cut off score of ≥1.700 and top three results 
matching, there was no statistical difference found 
between the rates of obtaining sub-culture concordant 
species level identifications using 10% SDS, 5% saponin 
or SepsiTyper to prepare monomicrobial positive blood 
cultures for direct MALDI-TOF. The rate of identifica-
tion for all three methods ranged from 69 to 74% using 
this lower cut off. With all three lysis methods, the lower 
score cut off value of ≥1.700 and top three results match-
ing increased the proportion of species level identifica-
tions by at least 12% more when compared to the more 
stringent ≥2.000 cut off value but did however yield two 
apparent discordances between MALDI-TOF and con-
ventional culture. Both apparent discordances were sub-
sequently found to be due to incomplete identification of 
cultured organisms and the results obtained by MALDI-
TOF were correct and corroborated by 16S PCR and 
sequencing.
We have demonstrated that up to 72% of bacteria in 
monomicrobial blood cultures can be identified on day 
one by MALDI-TOF. However polymicrobial cultures 
remain problematic for MALDI-TOF directly from blood 
culture as previously reported [11, 17]. In this study, 
where a direct identification was obtained from a culture 
that was polymicrobial on sub-culture, the identification 
was always consistent with one of the cultured organ-
isms. This suggests that the direct identifications from 
polymicrobial cultures, when obtained with the methods 
described, can be considered accurate for the organism 
identified (despite not giving identification of all organ-
isms) when making empirical clinical decisions, whilst 
awaiting technical confirmation. In common with sev-
eral other studies [5, 6] we found a higher proportion of 
identification by MALDI-TOF to species level for blood 
cultures containing Gram negative bacteria than Gram 
positive bacteria and reduced rates of successful identifi-
cation for streptococci.
The performance of the SepsiTyper kit has been evalu-
ated in at least 21 reported studies as recently reviewed 
by Morgenthaler and Kostrzewa [6]. The reported per-
centage identification to species level in monomicrobial 
cultures is variable across the studies from 56 to 100% 
and probably reflects the different methodologies and 
gold standards with which it was compared as well as 
possible differences in the proportions of different bac-
teria isolated from bacteraemic patients at different sites. 
When compared with alternative methods, SepsiTyper 
has been found to be superior to gel separator tubes 
[18], differential centrifugation [5, 13, 19] and another 
commercial preparation kit [19]. In agreement with this 
study, SepsisTyper has previously been found to compa-
rable with methods using lysis with saponin [4, 20] and 
SDS [5]. There are no previous reports comparing both 
Saponin and SDS.
For a clinical diagnostic laboratory, it is attractive to 
select the convenience of a commercially available, vali-
dated kit. However, the performance of any methodology 
will always need to be locally verified and operating costs 
are an increasingly important consideration. At the time 
of this evaluation, the cost per sample of the ready-made 
SDS or saponin reagent was 100 times lower than the 
cost of the Sepsityper kit with identical consumption of 
other consumables and staff time.
Identification of bacteria in the clinical diagnostic labo-
ratory by MALDI-TOF is still a developing technology. 
As MALDI-TOF is used increasingly as a direct identi-
fication method from blood cultures the databases and 
algorithms that support the identifications are likely to 
improve. During this study, the investigators interpreted 
the MALDI-TOF results in isolation from the Gram 
results and any clinical information. If this method were 
implemented, the results would be interpreted in the 
light of laboratory expertise, the Gram stain and clinical 
information which have been shown to improve correct 
identifications and minimise misidentifications [5, 7, 21, 
22]. Results from this study also suggest that the cut off 
score value to be selected for clinical use needs to balance 
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the benefits of a greater number of identifications on day 
one against the risks of possible misidentification, espe-
cially in the case of polymicrobial cultures. A number of 
studies have demonstrated clinical benefits from earlier 
direct identification of organisms in blood cultures by 
using MALDI-TOF [17, 23, 24]. One of our aims for the 
development of direct MALDI-TOF on positive cultures 
within our laboratory is to assess the potential clinical 
impact on patient care.
Conclusions
This study has demonstrated that two relatively inexpen-
sive in-house detergent lysis methods are non-inferior 
when compared with a commercially available kit for 
preparing positive blood cultures for direct MALDI-TOF 
in a large clinical diagnostic microbiology laboratory. 
Using a MALDI-TOF score cut off value of ≥1.700 and 
top three results matching for species level identifica-
tion gave reliable organism identifications from 72% of 
monomicrobial blood cultures and identified one of the 
organisms from polymicrobial cultures in 34–75% of 
samples depending on the method. No organisms were 
identified by MALDI-TOF in any samples that were truly 
discordant with the culture results.
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